These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 454816)

  • 21. Platelet malonyldialdehyde formation: an indicator of platelet hyperfunction.
    Stuart MJ
    Thromb Haemost; 1979 Aug; 42(2):649-54. PubMed ID: 505371
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reactions of platelets to various stimuli].
    Kobayashi B
    Rinsho Byori; 1979; Suppl 40():13-29. PubMed ID: 233104
    [No Abstract]   [Full Text] [Related]  

  • 23. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of procainamide on pulmonary thromboembolism and platelet malondialdehyde in mice.
    Pang JX; Sun LS; Wang XY; Yang SQ; Shan CW
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):500-2. PubMed ID: 9863141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electron microscopic study of the role of blood platelets in thrombogenesis].
    Krymskiĭ LD; Nestaĭkov GV; Stanishevskiĭ IuA
    Vestn Akad Med Nauk SSSR; 1973; 28(7):89-95. PubMed ID: 4362360
    [No Abstract]   [Full Text] [Related]  

  • 28. Proquazone (Sandoz 43-715), an unusually potent inhibitor of the platelet release reaction and malondialdehyde formation.
    Zucker MB
    Proc Soc Exp Biol Med; 1977 Nov; 156(2):209-12. PubMed ID: 928392
    [No Abstract]   [Full Text] [Related]  

  • 29. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
    Rajtar G; Livio M; Merino J; de Gaetano G
    Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet antiaggregating activity of imolamine: in vitro studies.
    Tremoli E; Maderna P; Cocuzza E; Mantero O
    Pharmacol Res Commun; 1979 Jan; 11(1):31-8. PubMed ID: 424437
    [No Abstract]   [Full Text] [Related]  

  • 31. Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms.
    Bastida E; Escolar G; Ordinas A; Jamieson GA
    J Lab Clin Med; 1986 Dec; 108(6):622-7. PubMed ID: 3783031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin-induced oxygen consumption, malonyldialdehyde formation and serotonin secretion in human platelets.
    Fukami MH; Holmsen H; Bauer J
    Biochim Biophys Acta; 1976 Mar; 428(1):253-6. PubMed ID: 1260021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
    Qu YZ; Li XX
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet hypersensitivity and intravascular coagulation in paroxysmal nocturnal hemoglobinuria.
    Steinberg D; Carvalho AC; Chesney CM; Colman RW
    Am J Med; 1975 Dec; 59(6):845-50. PubMed ID: 1190256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
    MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
    Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasoactive agents and production of thrombosis during intravascular coagulation 1--comparative effects of norepinephrine in thrombin and adenosine diphosphate (ADP) treated rabbits.
    Latour JG; Léger-Gauthier C; Daoust-Fiorilli J
    Pathology; 1984 Oct; 16(4):411-7. PubMed ID: 6522106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticlopidine - an antiplatelet drug: effects in human volunteers.
    O'Brien JR; Etherington MD; Shuttleworth RD
    Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of citrate on platelet aggregation and malondialdehyde production.
    Huijgens PC; van den Berg CA; Voetdijk AM; Imandt LM
    Scand J Haematol; 1983 Aug; 31(2):129-32. PubMed ID: 6412352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets.
    Plow EF; Ginsberg MH
    J Biol Chem; 1981 Sep; 256(18):9477-82. PubMed ID: 6270087
    [No Abstract]   [Full Text] [Related]  

  • 40. Epinephrine potentiation of platelet aggregation: its effect on death from experimental pulmonaryeembolism.
    Thomas DP; Gurewich V; Stuart RK
    J Lab Clin Med; 1968 Jun; 71(6):955-63. PubMed ID: 5654778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.